Avalo Therapeutics Inc. buy Wedbush
Start price
20.03.25
/
50%
€0.041
Target price
20.03.26
€16.51
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 20.03.26. The prediction end date can be changed by Wedbush at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Avalo Therapeutics Inc. | - | - |
| iShares Core DAX® | 0.754% | -1.027% |
| iShares Nasdaq 100 | -2.859% | -4.266% |
| iShares Nikkei 225® | 4.946% | 5.736% |
| iShares S&P 500 | -1.254% | -2.357% |
Comments by Wedbush for this prediction
In the thread Avalo Therapeutics Inc. diskutieren
Avalo Therapeutics, Inc. (NASDAQ: AVTX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
Stopped prediction by Wedbush for Avalo Therapeutics Inc.
Avalo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.041
21.02.25
21.02.25
€17.18
21.02.26
21.02.26
-
28.12.23
28.12.23
